Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab. Cell. 2017 Nov 02; 171(4):934-949.e16.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antineoplastic Agents
Genome-Wide Association Study
Humans
Immunotherapy
Melanoma
Programmed Cell Death 1 Receptor
T-Lymphocytes
Transcriptome
Tumor Microenvironment
authors with profiles
Thomas F. Gajewski